Category

Clinical Trials

Spago Nanomedical Research

Spago Nanomedical initiates clinical trial

February 20, 2019

The company has received approval …

Christer Nordstedt

Positive results from Orion trial

February 18, 2019

Orion’s and Bayer’s darolutamide shows …

Lundbeck Research

Phase III data from Lundbeck did not meet the primary endpoint

February 14, 2019

Lundbeck and Otsuka report new …

Cancer cells

First patient treated in Immunicum trial

February 11, 2019

The first patient has been …

laboratory

Orion and Bayer present new data from the Darolutamide ARAMIS -study

February 6, 2019

First presentation of data from …

LIDDS Research

LIDDS adds new clinic to their clinical trial

February 6, 2019

The company has received approval …

Magnus Doverskog

Umecrine Cognition announces results from a Phase 2a study

February 3, 2019

The Umeå-based company reports new …

cantargia

First patient treated in Cantargia trial

January 28, 2019

The first patient in the …

John Öhd

Modus Therapeutics completes enrollment of Phase II study

January 7, 2019

The company announces that it …

lundbeck-research

Lundbeck initiates new Phase II study

January 4, 2019

The company initiates a phase …

Richard Godfrey

BerGenBio starts new trial

January 4, 2019

The first patient has been …

AstraZeneca research

Two AstraZeneca trials have met primary endpoints

December 20, 2018

The Phase III OLYMPUS and …

Signing papers

Spago Nanomedical submitts clinical trial application

December 20, 2018

The company applied today with the …

Alligator Bioscience starts clinical phase I study

December 20, 2018

Regulatory approvals have been obtained …

xbrane-lab

Xbrane Biopharma has submitted its first CTA for the start of the Xplore trial

December 19, 2018

The company has submitted its …

cantargia

Cantargia reports positive results

December 10, 2018

All patients in the company’s …

1
2
3
···
22

English